Refers to solid-state, cloned lineage formulas that are suitable for oral management, and the method of preparing these formulas. The formula of the present description contains a polymer composed of AM sequence.2. Inoacidos Cys Cys Glu Tyr Cys Cys ASN Pro ala Cys thr Gly Cys Tyr ("linacotida") or one of the salts with acceptable efficacy. The hemophilia preparation described in this specification is stable and has a deposition life sufficient to manufactureStore and distribute pharmacy
展开▼
机译：指适用于口服治疗的固态克隆血统配方，以及制备这些配方的方法。本说明书的分子式包含由AM序列组成的聚合物。2。 Inoacidos Cys Cys Glu Tyr Cys Cys ASN Pro ala Cys thr Gly Cys Tyr（“ linacotida”）或一种具有可接受功效的盐。本说明书中所述的血友病制剂稳定且具有足以制造和储存药房的沉积寿命
展开▼
